| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(92)92414-B |
| P698 | PubMed publication ID | 1353239 |
| P2093 | author name string | M. J. Mills | |
| H. L. Makin | |||
| A. C. Newland | |||
| I. R. Grant | |||
| J. Cunningham | |||
| R. D. Coldwell | |||
| S. M. Kelsey | |||
| P433 | issue | 8814 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 316-317 | |
| P577 | publication date | 1992-08-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes | |
| P478 | volume | 340 |
| Q37808261 | A systems approach to bone pathophysiology |
| Q44081405 | Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells |
| Q33409795 | Differentiation therapy of leukemia: 3 decades of development |
| Q47684293 | Induction of Apoptosis in Human Leukaemia Cells is Differentially Regulated by Vitamin D Derivatives and Retinoids |
| Q77794161 | Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D |
| Q46613073 | Post transplant erythrocytosis in hypercalcemic renal transplant recipients |
| Q40383903 | Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant. |
| Q53957961 | Vitamin D treatment in myelodysplastic syndromes. |
| Q33759350 | Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy |
Search more.